{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:telmisartan",
  "owner": "cardio",
  "kind": "drug",
  "slug": "telmisartan",
  "name": "Telmisartan",
  "aliases": [
    "Micardis"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Telmisartan is an ARB (angiotensin II receptor blocker), a medicine taken by mouth. The US label read, for telmisartan tablets (a generic product), lists two uses: treating high blood pressure, and reducing the risk of heart attack (myocardial infarction), stroke or cardiovascular death in patients 55 or older at high risk who are unable to take ACE inhibitors. The label read is a generic product label; the brand names for this substance are recorded as aliases.",
  "summary_technical": "RxNorm ingredient 73494; UNII U5SYW473RQ. UNII U5SYW473RQ is the UNII of the substance as the label names it. MeSH descriptor D000077333 is Telmisartan. Class: Angiotensin 2 Receptor Blocker (FDA established pharmacologic class, RxClass). The label read is the Ascend Laboratories, LLC label for telmisartan tablets, application ANDA205150, effective 2025-03-29 in openFDA; Drugs@FDA lists the application's sponsor as ADAPTIS. The brand label for Micardis (listed as discontinued in Drugs@FDA), other generic telmisartan labels and the combination labels were not used. This page records label indications and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "73494",
      "normalized_value": "73494",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "U5SYW473RQ",
      "normalized_value": "U5SYW473RQ",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D000077333",
      "normalized_value": "D000077333",
      "match": "exact",
      "version": "read 2026-11-09",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels",
        "heart"
      ],
      "condition-area": [
        "hypertension",
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "a760ec635099a0180b5495d252d9e115c4efddd62fab90e479441b00110affec",
  "review": {
    "content_digest": "a760ec635099a0180b5495d252d9e115c4efddd62fab90e479441b00110affec",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-telmisartan-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:telmisartan",
      "category": "descriptive",
      "statement": "The US label of telmisartan tablets, USP, in the Ascend Laboratories, LLC version dated 2025-03-29 in openFDA (a generic product), lists the medicine for the treatment of hypertension, to lower blood pressure; and for reduction of the risk of heart attack (myocardial infarction), stroke or cardiovascular death in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors.",
      "context": {
        "id": "cardio:ctx-fda-telmisartan-label-us",
        "label": "Patients for whom the US label of telmisartan tablets lists an indication: hypertension, cardiovascular risk reduction in patients 55 or older at high risk who are unable to take ACE inhibitors",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The risk reduction indication names patients 55 years of age or older at high risk who are unable to take ACE inhibitors; the hypertension indication does not state an age range.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "55 years or older for the risk reduction indication, as the passage read states; not stated for hypertension",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with hypertension",
            "Patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read, and the label has a boxed warning section whose content was not read or recorded. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-telmisartan-ascend-2026-11-09",
            "retrieved_at": "2026-11-09T13:26:57Z",
            "content_hash": "13ec09d12943dd0899ef011d1e41530a3b174ce48e3dbf6df4fab4d2d936f9ee",
            "source_effective_date": "2025-03-29",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-telmisartan-ascend",
            "source_type": "regulator",
            "title": "openFDA drug label record for telmisartan tablets, USP, Ascend Laboratories, LLC label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2229bddc43-2809-4e1f-ae35-2865e15e9bb6%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 29bddc43-2809-4e1f-ae35-2865e15e9bb6 (manufacturer Ascend Laboratories, LLC, application ANDA205150), returned on 2026-11-09. The label text is dated 2025-03-29 (effective_time). Other openFDA records of telmisartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-telmisartan-ascend.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[1], 1.2 Cardiovascular Risk Reduction",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-telmisartan-ascend-2026-11-09",
            "retrieved_at": "2026-11-09T13:26:57Z",
            "content_hash": "13ec09d12943dd0899ef011d1e41530a3b174ce48e3dbf6df4fab4d2d936f9ee",
            "source_effective_date": "2025-03-29",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-telmisartan-ascend",
            "source_type": "regulator",
            "title": "openFDA drug label record for telmisartan tablets, USP, Ascend Laboratories, LLC label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2229bddc43-2809-4e1f-ae35-2865e15e9bb6%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 29bddc43-2809-4e1f-ae35-2865e15e9bb6 (manufacturer Ascend Laboratories, LLC, application ANDA205150), returned on 2026-11-09. The label text is dated 2025-03-29 (effective_time). Other openFDA records of telmisartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-telmisartan-ascend.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250329.",
          "snapshot": {
            "id": "cardio:openfda-label-telmisartan-ascend-2026-11-09",
            "retrieved_at": "2026-11-09T13:26:57Z",
            "content_hash": "13ec09d12943dd0899ef011d1e41530a3b174ce48e3dbf6df4fab4d2d936f9ee",
            "source_effective_date": "2025-03-29",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-telmisartan-ascend",
            "source_type": "regulator",
            "title": "openFDA drug label record for telmisartan tablets, USP, Ascend Laboratories, LLC label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2229bddc43-2809-4e1f-ae35-2865e15e9bb6%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 29bddc43-2809-4e1f-ae35-2865e15e9bb6 (manufacturer Ascend Laboratories, LLC, application ANDA205150), returned on 2026-11-09. The label text is dated 2025-03-29 (effective_time). Other openFDA records of telmisartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-telmisartan-ascend.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].products[0].brand_name",
          "applicability_note": "Drugs@FDA product listing for application ANDA205150, which confirms the product the label belongs to.",
          "snapshot": {
            "id": "cardio:drugsfda-anda205150-2026-11-09",
            "retrieved_at": "2026-11-09T13:26:58Z",
            "content_hash": "b4e8cbf33dbae999da26c62354a47273feb6e44843edb33850370266ed19bb56",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:drugsfda-anda205150",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for application ANDA205150 (TELMISARTAN, sponsor ADAPTIS): product and sponsor",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22ANDA205150%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA, Drugs@FDA)",
            "edition": "The openFDA Drugs@FDA record for application ANDA205150, returned on 2026-11-09. It lists the sponsor and the products of the application; only the first product listing is quoted.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short values are quoted. The raw record is committed at research/snapshots/wb22-drugsfda-telmisartan-ascend.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "55559a311143483eeb191fd62bc186ed78946453edc5b19808c63d47d8cfe2e9",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-telmisartan-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Telmisartan is an ARB (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:angiotensin-receptor-blockers-arbs",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-73494-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-telmisartan-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists reduction of the risk of myocardial infarction, stroke or cardiovascular death in people 55 or older at high risk who are unable to take ACE inhibitors as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:myocardial-infarction",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-telmisartan-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists reduction of the risk of myocardial infarction, stroke or cardiovascular death in people 55 or older at high risk who are unable to take ACE inhibitors as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:stroke",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-telmisartan-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01128322",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01128322-2011-04-26",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01180205",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01180205-2011-07-12",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01222520",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01222520-2014-06-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01830530",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01830530-2013-04-12",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01914432",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01914432-2014-07-08",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02373163",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02373163-2025-07-29",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03872232",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03872232-2021-01-15",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04158076",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04158076-2021-05-12",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04218552",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04218552-2021-07-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[3].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05843162",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05843162-2023-05-06",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct07932145",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07932145-2026-11-12",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda020850",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda020850-2022-12-19",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda021162",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda021162-2022-12-19",
          "locator": "products[0].active_ingredients[1].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda022401",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda022401-2018-02-01",
          "locator": "products[0].active_ingredients[1].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda219423",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda219423-2026-05-28",
          "locator": "products[0].active_ingredients[2].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/telmisartan/",
  "context_path": "api/v1/context/cardio--telmisartan.md"
}
